In chemico test for toxicity
AssigneeLebrun Labs LLC
InventorsStewart Lebrun, Linda Nguyen
Life of this patent
Estimating the term…
Abstract
The disclosure relates to formulations and methods for the in chemico testing of toxins based on a discovery that measuring a reduction in enzyme activity can be used to predict in vivo toxicity, including for example, a skin corrosion, skin irritation, eye corrosion, eye irritation, lung toxicity, liver toxicity, nervous system toxicity, developmental toxicity, acute toxicity etc. Disclosed methods are rapid, easy to perform and shelf-stable approaches for identification of toxic chemicals and materials.
Claims19
A method for predicting the living dermal or ocular tissue irritancy, corrosiveness or toxicity of a test substance, the method comprising:
- applying the test substance to a predefined enzyme or enzyme mixture to effect an in chemico reaction, wherein the test substance does not preferentially or specifically bind to an active or regulatory site of the predefined enzyme or enzyme mixture, wherein the enzyme or enzyme mixture comprises a phosphatase and/or an esterase;
- measuring any reduction in enzymatic activity of the predefined enzyme or enzyme mixture on a predefined substrate;
- and,
- comparing the measured reduction in enzymatic activity to a control activity value or previously established activity value, and
- predicting the extent of, or classification of, living tissue toxicity of the test substance based on the compared measured reduction in enzymatic activity,
- wherein a reduction in enzymatic activity to 40% or less of control activity value or previously established value by said test substance indicates the test substance is corrosive or toxic to living dermal or ocular tissue, and wherein a reduction in enzymatic activity to a level which is more than 40% of control activity value or previously established value but equal to 60% or less of control activity value or previously established value indicates the test substance is an irritant to living dermal or ocular tissue.
Dependencies are inferred from the claim text.